Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Marts 2024

Genmab — Marts 2024

Planlagt Fastgjort Låst Flyttet Genmab
830 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • JørgenVarnæsJ Offline
    JørgenVarnæsJ Offline
    JørgenVarnæs
    wrote on sidst redigeret af
    #122

    Du kaldte mig en trold

    1 Reply Last reply
    0
    • L Offline
      L Offline
      lahn1
      wrote on sidst redigeret af
      #123

      JKY jeg er enig, men tør næsten ikke tanke om hvad der ville ske hvis Jan blev skiftet ud inden HexCD38 er afklaret. Måske han bare skal være lidt mere PÅ overfor aktionærene

      1 Reply Last reply
      0
      • L Offline
        L Offline
        lahn1
        wrote on sidst redigeret af
        #124

        Forvekslede dig måske med troldmanden 😉

        1 Reply Last reply
        0
        • J Offline
          J Offline
          JKY_VH
          wrote on sidst redigeret af
          #125

          lahn1, hvis jeg skal komme med et frisk bud så vil aktien falde 8-10% i tossetimen på den nyhed og så vil jeg personligt supplere, hvis jeg har mulighed for det;-)

          1 Reply Last reply
          0
          • K Offline
            K Offline
            Klarussen
            wrote on sidst redigeret af
            #126

            Frisk TA-opdatering fra Investtech: https://www.investtech.com/dk/market.php?CompanyID=45104599&tck=genmab

            1 Reply Last reply
            0
            • JørgenVarnæsJ Offline
              JørgenVarnæsJ Offline
              JørgenVarnæs
              wrote on sidst redigeret af
              #127

              Hvorfor skulle aktien falde? Altså ud over den omkostning, der vil være forbundet med at købe JvdW ud?

              1 Reply Last reply
              0
              • J Offline
                J Offline
                JKY_VH
                wrote on sidst redigeret af
                #128

                Nå ja, det er jo set før i verdenshistorien at aktier falder når en respekteret CEO træder tilbage.

                1 Reply Last reply
                0
                • L Offline
                  L Offline
                  lahn1
                  wrote on sidst redigeret af
                  #129

                  Tror ikke vi er der, hvor det generelle markede vil se en udskiftning af Jan som en positiv nyhed. Under alle omstændigheder vil det skabe ydereligere usikkerhed.

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #130

                    Epcoritamab, a Promising Therapy for Richter Syndrome? https://www.hematologyandoncology.net/archives/march-2024/epcoritamab-a-promising-therapy-for-richter-syndrome/

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #131

                      AACR Annual Meeting 2024 Abstract titles via
                      https://www.abstractsonline.com/pp8/#!/20272/presentations/epcoritamab/1

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #132

                        the Inclacumab trial still going and seems fully recruited. Primary Completion this summer. I had a very low probability on this
                        , but who knows... https://classic.clinicaltrials.gov/ct2/history/NCT04935879?B=11&A=10&C=merged#StudyPageTop

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #133

                          HC Wainwright restated a "buy" rating and issued a $50.00 price target on shares of Genmab A/S in a report on Wednesday.

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #134

                            Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab)-based quadruplet therapy for the treatment of patients with transplant-eligible, newly diagnosed multiple myeloma / PERSEUS https://www.globenewswire.com/news-release/2024/03/06/2841454/0/en/Johnson-Johnson-submits-application-to-the-European-Medicines-Agency-for-DARZALEX-daratumumab-based-quadruplet-therapy-for-the-treatment-of-patients-with-transplant-eligible-newly-.html

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #135

                              Daratumumab in Pediatric Heart Transplantation. https://twitter.com/PHTSociety/status/1765385728102404100/photo/1

                              1 Reply Last reply
                              0
                              • L Offline
                                L Offline
                                lahn1
                                wrote on sidst redigeret af
                                #136

                                Tak EL !

                                1 Reply Last reply
                                0
                                • troldmandenT Offline
                                  troldmandenT Offline
                                  troldmanden
                                  wrote on sidst redigeret af
                                  #137

                                  Novo har lige fremhævet Mim8. At det er en prioritet at maximize Mim8 muligheden

                                  1 Reply Last reply
                                  0
                                  • R Offline
                                    R Offline
                                    Riis7
                                    wrote on sidst redigeret af
                                    #138

                                    Genmab skal ha det Novo tager;-)

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #139

                                      https://www.morningstar.com/company-reports/1211878-genmab-strong-royalty-revenue-from-darzalex-provides-ample-cash-flow-shares-undervalued?listing=0P0000A5QU morningstar maintains fair value target of 2650

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        peter12
                                        wrote on sidst redigeret af
                                        #140

                                        Nu skal der sælges epo https://www.roi-nj.com/2024/03/07/healthcare/genmab-promising-to-add-300-jobs-to-2nd-location-in-plainsboro-gets-8-4m-emerge-tax-credit/

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          kkjoel
                                          wrote on sidst redigeret af
                                          #141

                                          Stærkt fund, Peter
                                          🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper